These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10913166)

  • 21. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.
    Wasylyk C; Gutman A; Nicholson R; Wasylyk B
    EMBO J; 1991 May; 10(5):1127-34. PubMed ID: 1850695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition.
    Baillat D; Bègue A; Stéhelin D; Aumercier M
    J Biol Chem; 2002 Aug; 277(33):29386-98. PubMed ID: 12034715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
    Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
    J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity.
    Kwiatkowski BA; Bastian LS; Bauer TR; Tsai S; Zielinska-Kwiatkowska AG; Hickstein DD
    J Biol Chem; 1998 Jul; 273(28):17525-30. PubMed ID: 9651344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation.
    Maki K; Arai H; Waga K; Sasaki K; Nakamura F; Imai Y; Kurokawa M; Hirai H; Mitani K
    Mol Cell Biol; 2004 Apr; 24(8):3227-37. PubMed ID: 15060146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene.
    Contente S; Kenyon K; Sriraman P; Subramanyan S; Friedman RM
    Mol Cell Biochem; 1999 Apr; 194(1-2):79-91. PubMed ID: 10391127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood.
    Stegmaier K; Pendse S; Barker GF; Bray-Ward P; Ward DC; Montgomery KT; Krauter KS; Reynolds C; Sklar J; Donnelly M
    Blood; 1995 Jul; 86(1):38-44. PubMed ID: 7795247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9.
    Chakrabarti SR; Sood R; Ganguly S; Bohlander S; Shen Z; Nucifora G
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7467-72. PubMed ID: 10377438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of a dominant-negative DeltaETS TEL/ETV6 isoform.
    Sasaki K; Nakamura Y; Maki K; Waga K; Nakamura F; Arai H; Imai Y; Hirai H; Mitani K
    Biochem Biophys Res Commun; 2004 May; 317(4):1128-37. PubMed ID: 15094386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
    Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
    Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
    Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
    Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
    Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ
    Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene.
    Buttice G; Kurkinen M
    J Biol Chem; 1993 Apr; 268(10):7196-204. PubMed ID: 8463255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein.
    Guidez F; Petrie K; Ford AM; Lu H; Bennett CA; MacGregor A; Hannemann J; Ito Y; Ghysdael J; Greaves M; Wiedemann LM; Zelent A
    Blood; 2000 Oct; 96(7):2557-61. PubMed ID: 11001911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components.
    Van Rompaey L; Dou W; Buijs A; Grosveld G
    Neoplasia; 1999 Dec; 1(6):526-36. PubMed ID: 10935500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemopoietic transformation by the TEL/ABL oncogene.
    Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
    Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts.
    Contente S; Attard FA; Yeh TJ; Buchhagen DL; Friedman RM
    J Interferon Cytokine Res; 2003 Nov; 23(11):639-47. PubMed ID: 14651778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6.
    Gu X; Shin BH; Akbarali Y; Weiss A; Boltax J; Oettgen P; Libermann TA
    J Biol Chem; 2001 Mar; 276(12):9421-36. PubMed ID: 11108721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.